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Conclusions: This study provides a comprehensive assessment of a
wide range of potential patient and surgical predictors associated with
outcomes of THR and the results will be useful to inform decision
making. A strength of this study is the large sample, repeated measures
of outcome over 5-years, and comprehensive internal validation
of prognostic models using multiple imputation and bootstrapping
methods. Although we identiﬁed a number of signiﬁcant predictors of
outcome, most of the difference in outcomes were predicted by the
baseline OHS, with little effect of other patient and surgical factors.
These patient groups still receiving substantial beneﬁt from surgery, for
example both obese and non obese groups receive great improvement,
even though there are small differences in pain/function at outcome
(Figure 2). Better measures of existing predictive variables, and other
factors, need to be identiﬁed that explain a greater proportion of the
variability in outcome to support patients and clinicians in making a
decision about surgery.
34
OUTCOMES FOLLOWING TOTAL KNEE REPLACEMENT SURGERY FOR
OA: THERE IS MORE THAN JUST THE KNEE TO CONSIDER
A.V. Perruccio1, J.D. Power1, E.M. Badley1, R. Gandhi2, N.N. Mahomed2,
A.M. Davis1. 1Toronto Western Res. Inst.; Univ. of Toronto, Toronto, ON,
Canada; 2Toronto Western Hosp.; Univ. of Toronto, Toronto, ON, Canada
Purpose: The most common outcomes examined in total knee
replacement (TKR) for osteoarthritis (OA) are pain and physical function.
And, TKR is an effective treatment for relieving pain and improving
function. While people with OA often have multiple symptomatic joints,
however, the impact of this on these TKR outcomes has received little
attention. This work evaluated whether the occurrence and location
of symptomatic joints predicted change in WOMAC pain and physical
function following TKR, and whether multiple joint involvement was
associated with the likelihood of achieving a minimally clinically
important difference (MCID) in pain and function. The inﬂuence of
multiple joint involvement on a number of additional TKR outcomes
was also examined.
Methods: Participants (n = 494) completed pain and physical function
measures (WOMAC, KOOS (which subsumes the WOMAC) and CPG),
sports/recreation (KOOS), fatigue (POMS), and anxiety and depression
(HADS) pre surgery and at 12 months post surgery. Comorbidity was
based on number of conditions. Symptomatic joints were indicated on a
homunculus based on pain or discomfort on most days of the previous
month. Symptomatic joints were separately considered as a summative
count and by joint site as an independent predictor of change in WOMAC
pain and function by way of regression analyses, adjusting for covariates:
age, sex, BMI, comorbidity, and baseline status for each measure. Logistic
regression analyses examined the effect of joint involvement (count and
site) on achieving an MCID on WOMAC pain and function, adjusted for
covariates. Finally, the effect of joint involvement on change in the other
outcomes was also examined.
Results: Ages ranged from 35–88 years (mean = 65) with 65% female.
15% of the sample was symptomatic in only their surgical joint; 46%
reported ≥5 symptomatic joints. Mean change scores across all measures
varied depending on whether speciﬁc joint sites were indicated. The least
amount of change was observed among participants reporting feet/ankle
and neck as problematic joints. This was conﬁrmed in regression
analyses. Adjusting for covariates and all joint sites, individuals reporting
neck problems had less change across all measures (p range: 0.0020–
0.0493), except KOOS sport/rec. Individuals reporting feet/ankles also had
less change across measures (p range: 0.0002–0.0136), except fatigue and
anxiety. For fatigue, back problems were also associated with less change.
Although joint count was a signiﬁcant predictor across all measures,
except KOOS sport/rec, the magnitude of the coefﬁcients were highly
attenuated in comparison to some speciﬁc joint sites, particularly neck
and feet/ankle. Adjusted for covariates, baseline status, and all joint sites,
logistic regression results indicated that individuals reporting feet/ankle
had reduced odds of achieving a MCID for WOMAC pain (OR: 0.32, 95%CI:
0.185, 0.544) and function (OR: 0.53, 95%CI: 0.303, 0.940). Additionally,
individuals reporting neck problems had reduced odds of achieving a
MCID for WOMAC physical function (OR: 0.37, 95%CI: 0.183, 0.726).
Conclusions: While TKR is an effective treatment, these study results
suggest that TKR outcomes may be further improved if a more holistic
approach to OA management were adopted. While systemic effects may
be operational in OA, the contribution of speciﬁc joints is unclear.
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Purpose: Several studies have explored the socioeconomic burden of
osteoarthritis (OA). However, although treatment guidelines uniformly
recommend a multidisciplinary approach to OA pain management, a
thorough evaluation of the use and costs of alternative treatments for
the management of OA is lacking. The objective of this study was to
evaluate the use and direct medical costs of pharmacologic and non-
pharmacologic (alternative) treatments for patients with OA in usual
care settings in the United States.
Methods: Using the LifeLink™ Health Plan Claims Database, all patients
at least 18 years of age, with one or more healthcare encounters
with an associated diagnosis of OA (ICD-9-CM code 715.XX) during
each of calendar years (CY) 2007 and 2008 were identiﬁed. OA
patients who were continuously enrolled during CY2008 and received
a prescription for non-selective nonsteroidal anti-inﬂammatory drugs
(NS-NSAIDs), Cyclooxygenase-2 inhibitors (Cox-2s), acetaminophen,
tramadol, weak opioids and strong opioids any time during the year
were then selected. Patterns of pain-related pharmacotherapy, alternative
treatments and direct medical costs associated with these therapies,
as well as total healthcare costs (ofﬁce visits, emergency room visits,
hospitalizations, other outpatient services) were examined among this
group of patients during CY2008. Additionally, adherence to select pain-
related medications was also evaluated using a Medication Possession
Ratio (MPR).
Results: A total of 64,085 OA patients were included in the
analysis (average age: 56.4±9.3 years; 63% female). Patients had
multiple comorbidities (hypertension, 56%; hyperlipidemia, 52%;
gastroesophageal reﬂux disease, 19%; low back pain, 36%; back and
neck pain with neuropathic involvement, 17%) and a substantial pain
and adjuvant medication burden. Opioids were the most commonly
prescribed pain-related medication (72%), followed by NS-NSAIDs (55%);
32% of patients received antidepressants, 21% received benzodiazepines,
and 15% received sedative hypnotics during CY2008. Nearly 1 out of
4 (23%) patients used assistive devices, 20% had physical therapy, 11% saw
a chiropractor and 14% received TENS during CY2008. Use of treatments
like acupuncture, hydrotherapy, massage therapy, and biofeedback was
less than 2%. Less than 30% of patients achieved an MPR in excess of
80% for any of the evaluated medication classes with the average (±SD)
MPR being the highest for Cox-2 inhibitors (55% ± 29%). Mean (SD)
total healthcare costs among these patients were $15,614 ($22,581);
pharmacologic therapies accounted for 21% of these costs, whereas
alternative treatments accounted for only 3% of the total costs.
Conclusions: Results suggest that OA patients who received pain-related
medications had a high prevalence of comorbidities, and also used
adjuvant medications commonly prescribed for pain associated sequelae
including anxiety, depression, and sleep disorders. Although, non-
pharmacologic therapies are widely recommended, we found limited
use of many of these treatments in usual care. However, the observed
low use might be partly due to the source of our data (commercial
claims), since alternative treatments might be paid out-of-pocket by
patients. Further research is needed to ascertain the extent to which
such therapies contribute to the total costs of OA management.
36
A HIGH PREVALENCE AND IMPACT OF CHRONIC JOINT SYMPTOMS
IN THE YOUNGER POPULATION: IS THIS OSTEOARTHRITIS?
M. Canizares, E.M. Badley. Univ. Hlth.Networks, Toronto, ON, Canada
Purpose: Arthritis is one the most common chronic conditions affecting
15%-20% of the population. Estimates from population surveys show a
further 10%-15% of the population reporting chronic joint symptoms
(CJS). CJS have been considered as an indication of possible arthritis
with studies showing conﬂicting results. Most of these studies have
compared individuals with CJS to those with arthritis in terms of their
predictors and only a minority have considered health-related outcomes.
This study examines predictors and health outcomes for individuals with
